Our findings suggest that Solamargine is a promising anti-malignant melanoma drug which warrants further attention.
No takes yet. Share an insight, caveat, or question.
Sinani et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: